Abvc Biopharma Stock Forecast

Buy or Hold candidate since Jun 11, 2026 Gain 37.40%

The ABVC BioPharma, Inc. stock price gained 1.69% on the last trading day (Thursday, 2nd Jul 2026), rising from $1.77 to $1.80. It has now gained 7 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 5.88% from a day low at $1.70 to a day high of $1.80. The price has risen in 7 of the last 10 days and is up by 32.35% over the past 2 weeks. Volume fell on the last day by -158 thousand shares and in total, 119 thousand shares were bought and sold for approximately $213.83 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

Given the current short-term trend, the stock is expected to rise 15.58% during the next 3 months and, with a 90% probability hold a price between $1.34 and $2.08 at the end of this 3-month period.

ABVC Signals & Forecast

The ABVC BioPharma, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.58 and $1.32. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, May 11, 2026, and so far it has risen 76.47%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for ABVC BioPharma, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $1.45 and $1.39. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, ABVC BioPharma, Inc. finds support just below today's level at $1.45. If this is broken, then the next support from accumulated volume will be at $1.39 and $1.36.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.100 between high and low, or 5.88%. For the last week the stock has had daily average volatility of 9.33%.

Since the ABVC BioPharma, Inc. has been rising for 7 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Our recommended stop-loss: $1.75 (-2.90%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 36 days ago.)

Trading Expectations (ABVC) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect ABVC BioPharma, Inc. to open at $1.77, and during the day (based on 14 day Average True Range), to move between $1.74 and $1.86, which gives a possible trading interval of +/-$0.130 (+/-7.49%) up or down from last closing price. If ABVC BioPharma, Inc. takes out the full calculated possible swing range there will be an estimated 7.49% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $1.45, some $0.350 (19.44%) from the current price of $1.80, our system finds the risk reward attractive.

Is ABVC BioPharma, Inc. stock A Buy?

ABVC BioPharma, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Strong Buy candidate.

Current score: 5.500 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $1.77 ( 1.85%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk